Global Avascular Necrosis Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3426

Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.
Known by other names such as osteonecrosis or bone infarction, the condition is gaining global awareness thus supporting the growth of the AVN market. The disease which more commonly afflicts men between the ages of 30 to 50 years, has been highly prevalent in emerging economies.
In 2018, the global Avascular Necrosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Avascular Necrosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Avascular Necrosis development in United States, Europe and China.

The key players covered in this study
Stryker
Medtronic
Smith and Nephew
Ethicon
Sanofi
Bayer
Pfizer
Merck
Boehringer Ingelheim
Eli Lilly
Aurobindo Pharma
Integra LifeSciences
Zimmer Biomet
Wright Medical
Grifols

Market segment by Type, the product can be split into
Trauma Related Avascular Necrosis (AVN)
Non-Trauma Related Avascular Necrosis (AVN)

Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Avascular Necrosis status, future forecast, growth opportunity, key market and key players.
To present the Avascular Necrosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Avascular Necrosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Avascular Necrosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Trauma Related Avascular Necrosis (AVN)
1.4.3 Non-Trauma Related Avascular Necrosis (AVN)
1.5 Market by Application
1.5.1 Global Avascular Necrosis Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Avascular Necrosis Market Size
2.2 Avascular Necrosis Growth Trends by Regions
2.2.1 Avascular Necrosis Market Size by Regions (2014-2025)
2.2.2 Avascular Necrosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Avascular Necrosis Market Size by Manufacturers
3.1.1 Global Avascular Necrosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Avascular Necrosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Avascular Necrosis Market Concentration Ratio (CR5 and HHI)
3.2 Avascular Necrosis Key Players Head office and Area Served
3.3 Key Players Avascular Necrosis Product/Solution/Service
3.4 Date of Enter into Avascular Necrosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Avascular Necrosis Market Size by Type (2014-2019)
4.2 Global Avascular Necrosis Market Size by Application (2014-2019)

5 United States
5.1 United States Avascular Necrosis Market Size (2014-2019)
5.2 Avascular Necrosis Key Players in United States
5.3 United States Avascular Necrosis Market Size by Type
5.4 United States Avascular Necrosis Market Size by Application

6 Europe
6.1 Europe Avascular Necrosis Market Size (2014-2019)
6.2 Avascular Necrosis Key Players in Europe
6.3 Europe Avascular Necrosis Market Size by Type
6.4 Europe Avascular Necrosis Market Size by Application

7 China
7.1 China Avascular Necrosis Market Size (2014-2019)
7.2 Avascular Necrosis Key Players in China
7.3 China Avascular Necrosis Market Size by Type
7.4 China Avascular Necrosis Market Size by Application

8 Japan
8.1 Japan Avascular Necrosis Market Size (2014-2019)
8.2 Avascular Necrosis Key Players in Japan
8.3 Japan Avascular Necrosis Market Size by Type
8.4 Japan Avascular Necrosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Avascular Necrosis Market Size (2014-2019)
9.2 Avascular Necrosis Key Players in Southeast Asia
9.3 Southeast Asia Avascular Necrosis Market Size by Type
9.4 Southeast Asia Avascular Necrosis Market Size by Application

10 India
10.1 India Avascular Necrosis Market Size (2014-2019)
10.2 Avascular Necrosis Key Players in India
10.3 India Avascular Necrosis Market Size by Type
10.4 India Avascular Necrosis Market Size by Application

11 Central & South America
11.1 Central & South America Avascular Necrosis Market Size (2014-2019)
11.2 Avascular Necrosis Key Players in Central & South America
11.3 Central & South America Avascular Necrosis Market Size by Type
11.4 Central & South America Avascular Necrosis Market Size by Application

12 International Players Profiles
12.1 Stryker
12.1.1 Stryker Company Details
12.1.2 Company Description and Business Overview
12.1.3 Avascular Necrosis Introduction
12.1.4 Stryker Revenue in Avascular Necrosis Business (2014-2019)
12.1.5 Stryker Recent Development
12.2 Medtronic
12.2.1 Medtronic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Avascular Necrosis Introduction
12.2.4 Medtronic Revenue in Avascular Necrosis Business (2014-2019)
12.2.5 Medtronic Recent Development
12.3 Smith and Nephew
12.3.1 Smith and Nephew Company Details
12.3.2 Company Description and Business Overview
12.3.3 Avascular Necrosis Introduction
12.3.4 Smith and Nephew Revenue in Avascular Necrosis Business (2014-2019)
12.3.5 Smith and Nephew Recent Development
12.4 Ethicon
12.4.1 Ethicon Company Details
12.4.2 Company Description and Business Overview
12.4.3 Avascular Necrosis Introduction
12.4.4 Ethicon Revenue in Avascular Necrosis Business (2014-2019)
12.4.5 Ethicon Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Avascular Necrosis Introduction
12.5.4 Sanofi Revenue in Avascular Necrosis Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Avascular Necrosis Introduction
12.6.4 Bayer Revenue in Avascular Necrosis Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Avascular Necrosis Introduction
12.7.4 Pfizer Revenue in Avascular Necrosis Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Avascular Necrosis Introduction
12.8.4 Merck Revenue in Avascular Necrosis Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Avascular Necrosis Introduction
12.9.4 Boehringer Ingelheim Revenue in Avascular Necrosis Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 Avascular Necrosis Introduction
12.10.4 Eli Lilly Revenue in Avascular Necrosis Business (2014-2019)
12.10.5 Eli Lilly Recent Development
12.11 Aurobindo Pharma
12.12 Integra LifeSciences
12.13 Zimmer Biomet
12.14 Wright Medical
12.15 Grifols

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details